Open AccessMedicine

J. Gabert, E. Beillard, V. Velden, W. Bi, D. Grimwade, N. Pallisgaard, G. Barbany, G. Cazzaniga, J. Cayuela, H. Cavé, F. Pane, J. Aerts, D. Micheli, X. Thirion, V. Pradel, Marcos González, S. Viehmann, M. Malec, G. Saglio, J. Dongen

2003.12.1LEUKEMIA

DOI: 10.1038/sj.leu.2403135

tlooto Summary

The development of standardized protocols for RQ-PCR analysis of FG transcripts provides a milestone for molecular determination of MRD levels and is likely to prove invaluable to the management of patients entered into multicenter therapeutic trials.

Abstract

Abstract is not available.

Citation format

GABERT, J., et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a europe against cancer program. LEUKEMIA, 2003, 17: 2318–2357.